Can rare disease research in the US thrive under the new administration?
In 2024, 50% of the novel drugs approved by the FDA had an orphan drug designation. In the last two…
In 2024, 50% of the novel drugs approved by the FDA had an orphan drug designation. In the last two…
US Food and Drug Administration (FDA) Commissioner Dr. Marty Makary addressed concerns about the recent cuts impacting the agency’s ability…
The US Food and Drug Administration (FDA) has created a new priority review voucher (PRV) framework to expedite the drug…
“The science is brilliant in Europe, but the translation is what’s lacking,” said V-Bio Ventures managing partner Christina Takke on…
Pharma companies are looking to shore up manufacturing operations in the US to counter international tariffs, but are also bracing…
The US government has signalled a major shift in its trade policies in recent weeks, with several announcements detailing plans…
Eli Lilly will buy Boston biotech Scorpion Therapeutics’ PI3Kα inhibitor for upto $2.5bn in cash, with the latter splitting away…
President-elect Donald Trump has appointed Robert F Kennedy Jr, popularly known as RFK Jr, as the secretary of the premier…
After trialling a subscription-style system for procuring antimicrobial drugs, the UK’s National Health Service recently announced that it will formalise…
The ongoing European Union (EU) elections, a revision of key legislation governing the pharmaceutical and biotech industry in Europe, and…